• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全细胞百日咳疫苗和无细胞百日咳疫苗在儿童中诱导产生的不同T细胞亚群。

Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.

作者信息

Ryan M, Murphy G, Ryan E, Nilsson L, Shackley F, Gothefors L, Oymar K, Miller E, Storsaeter J, Mills K H

机构信息

Department of Biology, National University of Ireland, Maynooth, Ireland.

出版信息

Immunology. 1998 Jan;93(1):1-10. doi: 10.1046/j.1365-2567.1998.00401.x.

DOI:10.1046/j.1365-2567.1998.00401.x
PMID:9536112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1364099/
Abstract

Recent clinical trials have demonstrated that new generation acellular pertussis vaccines can confer protection against whooping cough. However, the mechanism of protective immunity against Bordetella pertussis infection induced by vaccination remains to be defined. We have examined cellular immune responses in children immunized with a range of acellular and whole cell pertussis vaccines. Immunization of children with a potent whole-cell vaccine induced B. pertussis-specific T cells that secreted interferon-gamma (IFN-gamma), but not interleukin-5 (IL-5). In contrast, T cells from children immunized with acellular pertussis vaccines secreted IFN-gamma and/or IL-5 following stimulation with B. pertussis antigens in vitro. These observations suggest that protective immunity conferred by whole-cell vaccines, like natural immunity, is mediated by type 1 T cells, whereas the mechanism of immune protection generated with acellular vaccines may be more heterogeneous, involving T cells that secreted type 1 and type 2 cytokines.

摘要

近期的临床试验表明,新一代无细胞百日咳疫苗可提供针对百日咳的保护。然而,接种疫苗诱导的针对百日咳博德特氏菌感染的保护性免疫机制仍有待确定。我们检测了接种一系列无细胞和全细胞百日咳疫苗的儿童的细胞免疫反应。用强效全细胞疫苗免疫儿童可诱导出分泌γ干扰素(IFN-γ)但不分泌白细胞介素-5(IL-5)的百日咳博德特氏菌特异性T细胞。相比之下,接种无细胞百日咳疫苗的儿童的T细胞在体外用百日咳博德特氏菌抗原刺激后会分泌IFN-γ和/或IL-5。这些观察结果表明,全细胞疫苗赋予的保护性免疫,如同天然免疫一样,由1型T细胞介导,而无细胞疫苗产生的免疫保护机制可能更为多样,涉及分泌1型和2型细胞因子的T细胞。

相似文献

1
Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.全细胞百日咳疫苗和无细胞百日咳疫苗在儿童中诱导产生的不同T细胞亚群。
Immunology. 1998 Jan;93(1):1-10. doi: 10.1046/j.1365-2567.1998.00401.x.
2
Different T cell memory in preadolescents after whole-cell or acellular pertussis vaccination.婴儿期全程或无细胞百白破疫苗接种后不同的 T 细胞记忆。
Vaccine. 2013 Dec 17;32(1):111-8. doi: 10.1016/j.vaccine.2013.10.056. Epub 2013 Oct 29.
3
Immunization with whole cell but not acellular pertussis vaccines primes CD4 T cells that sustain protective immunity against nasal colonization with Bordetella pertussis.全细胞而非无细胞百日咳疫苗免疫可诱导 CD4 T 细胞,维持对百日咳博德特氏菌鼻定植的保护性免疫。
Emerg Microbes Infect. 2019;8(1):169-185. doi: 10.1080/22221751.2018.1564630.
4
Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.用无细胞百日咳疫苗对儿童进行加强免疫可增强Th2细胞因子的产生以及针对百日咳毒素的血清IgE反应,但对常见过敏原则无此作用。
Clin Exp Immunol. 2000 Aug;121(2):193-200. doi: 10.1046/j.1365-2249.2000.01306.x.
5
Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.婴儿初次接种全细胞或无细胞百日咳疫苗后疫苗及抗原依赖性1型和2型细胞因子的诱导情况
Infect Immun. 1997 Jun;65(6):2168-74. doi: 10.1128/iai.65.6.2168-2174.1997.
6
A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.一种小鼠模型显示,其保护作用与儿童百日咳疫苗效力相关,揭示了体液免疫和细胞介导免疫在抵抗百日咳博德特氏菌感染中的互补作用。
Infect Immun. 1998 Feb;66(2):594-602. doi: 10.1128/IAI.66.2.594-602.1998.
7
T-cell immune response assessment as a complement to serology and intranasal protection assays in determining the protective immunity induced by acellular pertussis vaccines in mice.在确定无细胞百日咳疫苗在小鼠中诱导的保护性免疫时,T细胞免疫反应评估作为血清学和鼻内保护试验的补充。
Clin Diagn Lab Immunol. 2003 Jul;10(4):637-42. doi: 10.1128/cdli.10.4.637-642.2003.
8
Persistence at one year of age of antigen-induced cellular immune responses in preterm infants vaccinated against whooping cough: comparison of three different vaccines and effect of a booster dose.在接种百日咳疫苗的早产儿中,一岁时抗原诱导的细胞免疫反应的持久性:三种不同疫苗的比较和加强剂量的影响。
Vaccine. 2013 Apr 8;31(15):1981-6. doi: 10.1016/j.vaccine.2013.02.004. Epub 2013 Feb 18.
9
Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses.2个月大婴儿感染百日咳博德特氏菌会促进1型T细胞反应。
J Immunol. 2003 Feb 1;170(3):1504-9. doi: 10.4049/jimmunol.170.3.1504.
10
Acellular pertussis booster in adolescents induces Th1 and memory CD8+ T cell immune response.无细胞百日咳加强疫苗在青少年中诱导 Th1 和记忆性 CD8+T 细胞免疫应答。
PLoS One. 2011 Mar 8;6(3):e17271. doi: 10.1371/journal.pone.0017271.

引用本文的文献

1
A novel outer membrane vesicle adjuvant improves vaccine protection against Bordetella pertussis.一种新型外膜囊泡佐剂可提高百日咳博德特氏菌疫苗的保护效果。
NPJ Vaccines. 2024 Oct 16;9(1):190. doi: 10.1038/s41541-024-00990-1.
2
Type 5 secretion system antigens as vaccines against Gram-negative bacterial infections.5型分泌系统抗原作为抗革兰氏阴性菌感染的疫苗
NPJ Vaccines. 2024 Sep 1;9(1):159. doi: 10.1038/s41541-024-00953-6.
3
Adaptive immune response to bordetella pertussis during vaccination and infection: emerging perspectives and unanswered questions.在疫苗接种和感染期间对百日咳博德特氏菌的适应性免疫反应:新出现的观点和未解决的问题。
Expert Rev Vaccines. 2024 Jan-Dec;23(1):705-714. doi: 10.1080/14760584.2024.2383745. Epub 2024 Jul 24.
4
Virus-like particles displaying the mature C-terminal domain of filamentous hemagglutinin are immunogenic and protective against respiratory infection in mice.展示丝状血凝素成熟 C 末端结构域的病毒样颗粒具有免疫原性,并能预防小鼠呼吸道感染。
Infect Immun. 2024 Aug 13;92(8):e0027024. doi: 10.1128/iai.00270-24. Epub 2024 Jul 18.
5
BECC438b TLR4 agonist supports unique immune response profiles from nasal and muscular DTaP pertussis vaccines in murine challenge models.BECC438b Toll样受体4激动剂在小鼠攻毒模型中支持来自鼻内和肌肉注射的白百破疫苗的独特免疫反应谱。
Infect Immun. 2024 Mar 12;92(3):e0022323. doi: 10.1128/iai.00223-23. Epub 2024 Feb 7.
6
T-cell immunity to SARS-CoV-2: what if the known best is not the optimal course for the long run? Adapting to evolving targets.针对 SARS-CoV-2 的 T 细胞免疫:如果已知的最佳方法从长远来看并非最优方案,那该怎么办?适应不断变化的靶标。
Front Immunol. 2023 Jun 14;14:1133225. doi: 10.3389/fimmu.2023.1133225. eCollection 2023.
7
and : Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations.以及:感染、免疫调节和疫苗考虑方面的异同。
Clin Microbiol Rev. 2023 Sep 21;36(3):e0016422. doi: 10.1128/cmr.00164-22. Epub 2023 Jun 12.
8
A semi high-throughput whole blood-based flow cytometry assay to detect and monitor -specific Th1, Th2 and Th17 responses.一种半高通量全血流式细胞术检测和监测特异性 Th1、Th2 和 Th17 反应的方法。
Front Immunol. 2023 Feb 6;14:1101366. doi: 10.3389/fimmu.2023.1101366. eCollection 2023.
9
Antibody avidity to pertussis toxin after acellular pertussis vaccination and infection.百日咳毒素抗体亲和性在无细胞百日咳疫苗接种和感染后。
Emerg Microbes Infect. 2023 Dec;12(1):e2174782. doi: 10.1080/22221751.2023.2174782.
10
Evaluation of Whole-Cell and Acellular Pertussis Vaccines in the Context of Long-Term Herd Immunity.在长期群体免疫背景下对全细胞百日咳疫苗和无细胞百日咳疫苗的评估。
Vaccines (Basel). 2022 Dec 20;11(1):1. doi: 10.3390/vaccines11010001.

本文引用的文献

1
A randomized double-blind trial comparing a two-component acellular to a whole-cell pertussis vaccine in Senegal.在塞内加尔进行的一项随机双盲试验,比较双组分无细胞百日咳疫苗与全细胞百日咳疫苗。
Vaccine. 1997 Oct;15(15):1606-12. doi: 10.1016/s0264-410x(97)00100-x.
2
Bordetella pertussis respiratory infection in children is associated with preferential activation of type 1 T helper cells.儿童百日咳博德特氏菌呼吸道感染与1型辅助性T细胞的优先激活有关。
J Infect Dis. 1997 May;175(5):1246-50. doi: 10.1086/593682.
3
Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.接种无细胞或全细胞百日咳疫苗儿童对百日咳博德特氏菌抗原的细胞介导和抗体反应。百日咳项目 - 细胞介导免疫工作组
Arch Pediatr Adolesc Med. 1997 Mar;151(3):283-9. doi: 10.1001/archpedi.1997.02170400069013.
4
Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.接种程序对无细胞和全细胞百日咳疫苗反应原性及抗体持久性的影响:实验室检测作为临床效果预测指标的价值
Vaccine. 1997 Jan;15(1):51-60. doi: 10.1016/s0264-410x(96)00112-0.
5
Interleukin-12 is produced by macrophages in response to live or killed Bordetella pertussis and enhances the efficacy of an acellular pertussis vaccine by promoting induction of Th1 cells.白细胞介素-12由巨噬细胞产生,作为对活的或灭活的百日咳博德特氏菌的应答,并通过促进Th1细胞的诱导来增强无细胞百日咳疫苗的效力。
Infect Immun. 1996 Dec;64(12):5295-301. doi: 10.1128/iai.64.12.5295-5301.1996.
6
Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine.接种三联无细胞百日咳疫苗后婴儿的百日咳特异性细胞介导免疫
Infect Immun. 1996 Oct;64(10):4078-84. doi: 10.1128/iai.64.10.4078-4084.1996.
7
Functional diversity of helper T lymphocytes.辅助性T淋巴细胞的功能多样性。
Nature. 1996 Oct 31;383(6603):787-93. doi: 10.1038/383787a0.
8
Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0.百日咳博德特氏菌获得性免疫中的Th1/Th2细胞二分法:体内启动和体外细胞因子检测技术中的变量会影响T细胞亚群分类为Th1、Th2或Th0。
Immunology. 1996 Mar;87(3):372-80. doi: 10.1046/j.1365-2567.1996.497560.x.
9
A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.一项关于双组分无细胞、五组分无细胞和全细胞百日咳疫苗的对照试验。
N Engl J Med. 1996 Feb 8;334(6):349-55. doi: 10.1056/NEJM199602083340602.
10
A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.两种无细胞百日咳疫苗和一种全细胞百日咳疫苗的对照试验。百日咳项目工作组。
N Engl J Med. 1996 Feb 8;334(6):341-8. doi: 10.1056/NEJM199602083340601.